Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11300322

Download in:

View as

General Info

PMID
11300322